Press releases

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Paris Course on...

Boston Scientific Corporation (NYSE: BSX) announced today that it has filed a lawsuit in Ireland against Conor Medsystems Ireland Ltd. (NASDAQ:...

Boston Scientific Corporation (NYSE: BSX) and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI)(NASDAQ: TSX:)(NASDAQ: ANP) announced...

Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of the VASOVIEW® 7 Endoscopic Vessel Harvesting System and VASOVIEW®...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference, which is being...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank Health Care Conference, which is being held May 2-3 in...

Boston Scientific Corporation (NYSE: BSX) today announced that it plans to implement all the recommendations contained in a draft report by the...

Boston Scientific Corporation (NYSE: BSX) today announced that the company's Board of Directors elected Kristina M. Johnson, Ph.D. and Nancy-Ann...

Boston Scientific Corporation (NYSE: BSX) announced today that it has increased the interest rate payable on its $400 million 5.50 percent senior...

Boston Scientific Corporation (NYSE: BSX) today announced that it has completed its combination with Guidant Corporation (NYSE: GDT), creating a...

Boston Scientific Corporation (NYSE: BSX) today announced it has received antitrust approval from the U.S. Federal Trade Commission (FTC) for its...

Boston Scientific Corporation (NYSE: BSX) today announced financial results for the first quarter ended March 31, 2006. Highlights: * Record net...

Boston Scientific Corporation (NYSE: BSX) today announced that the first patient in the PRISM (Precision® Implantable Stimulator for Migraine)...

Boston Scientific Corporation (NYSE: BSX) today announced that it has received antitrust clearance from the European Commission regarding its...

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2006...

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an agreement containing consent orders with the staff of the...

Boston Scientific Corporation (NYSE: BSX) today announced the newest addition to its broad portfolio of vascular access products with the launch of...

Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the shareholders of each...

(January 12, 2006)

(January 12, 2006)

Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its ZIPwire™ Hydrophilic Guide Wire, which has received clearance...

Boston Scientific Corporation (NYSE: BSX) welcomed recent results from studies presented at the annual American College of Cardiology Scientific...

Boston Scientific Corporation (NYSE: BSX) announced today that a U.S. District Court judge in Delaware has denied the Company's motion to overturn...

Boston Scientific Corporation (NYSE: BSX) today announced that it has made certain commitments to the Directorate-General for Competition of the...

Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that Institutional Shareholder...

Boston Scientific Corporation (NYSE: BSX) today welcomed an article in the Journal of the American Medical Association (JAMA) on the TAXUS V ISR...

Boston Scientific Corporation (NYSE: BSX) today announced preliminary six-month results from its ARRIVE II registry, confirming the...

Boston Scientific Corporation (NYSE: BSX) today welcomed results from the independent, multi-center STENT registry, the largest...

Boston Scientific Corporation (NYSE: BSX) today announced nine-month data from its TAXUS V ISR (in-stent restenosis) clinical...

Boston Scientific Corporation (NYSE: BSX) today announced that it plans to name a leadership team for its new Cardiac Rhythm Management (CRM)...

Boston Scientific Corporation (NYSE: BSX) today announced that it has submitted to the U.S. Food and Drug Administration (FDA) the final module of...

Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events at the annual American College of Cardiology...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 9th Annual Lehman Brothers 2006 Global Healthcare Conference, which is...

Boston Scientific Corporation (NYSE: BSX) and Guidant Corporation (NYSE: GDT) today announced that the Securities and Exchange...

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in SG Cowen & Co.'s 26th Annual Health Care Conference, which is being held...

(February 15, 2006) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received reimbursement approval from the French government for its TAXUS

(February 6, 2006)

(February 3, 2006) Boston Scientific Corporation (NYSE: BSX) today issued the following statement on a meeting between senior officials of the Company and senior officials of the U.S. Food and...

(February 1, 2006) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2006 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference, which is...

(January 31, 2006) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended December 31, 2005 on...

(January 26, 2006)

and Indianapolis, IN (January 25, 2006)

(January 23, 2006)

(January 18, 2006) -- Boston Scientific Corporation (NYSE: BSX) today announced the results of a five-year retrospective study on Peripherally Inserted Central Catheters (PICCs) with Pressure...

(January 17, 2006)

(January 17, 2006)

(January 11, 2006)

(January 9, 2006)

(January 8, 2006)

(January 8, 2006)

(January 5, 2006) -- Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer Jim Tobin has agreed to a request from the Board of Directors to extend...

(January 4, 2006) -- Boston Scientific Corporation (NYSE: BSX) today announced that the Centers for Medicare and Medicaid Services (CMS) has approved its application for a transitional...

(February 7, 2006) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the year and fourth quarter ended December 31, 2005. 2005 HIGHLIGHTS Net sales of $6.283...

(December 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced it has made a $250,000 gift to Doctors Without Borders, an international medical humanitarian organization, in...

(December 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced a $500,000 contribution to the University of Minnesota Foundation to fund the creation of a Boston Scientific...

(December 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling all Flextome Cutting Balloon

(December 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has been recognized with the American Red Cross

(December 7, 2005)

(December 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that two of its senior executives are scheduled to participate in the first annual Massachusetts Conference for...

(December 5, 2005)

(November 23, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in The Fifth Annual Merrill Lynch Med Tech Fundamentals Conference, which is being held on Thursday,...

(November 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the completion of a public offering of $750 million aggregate principal amount of its senior notes under the Company

(November 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the pricing of a public offering of $750 million aggregate principal amount of its senior notes under the Company

(November 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to begin a prospective, randomized,...

and Vancouver, B.C. (November 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP) announced today that they have jointly received the...

(November 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that the Centers for Medicare and Medicaid Services (CMS) has approved its application for a new series of...

(October 31, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the CIBC World Markets Sixteenth Annual Healthcare Conference, which is being held November 7-9 in...

(October 25, 2005)

(October 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has acquired a portfolio of proprietary endoscopic stent technologies from Willy Rüsch GmbH (Rüsch), a...

and Washington, D.C. (October 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced 30-day safety data from the transitional phase of its OLYMPIA registry. The OLYMPIA registry is...

and Washington, D.C. (October 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the...

and Washington, D.C. (October 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) was recognized by physicians as a leader in the pursuit of evidence-based medicine through increased use of...

and Washington, D.C. (October 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced follow-up data supporting excellent long-term safety and efficacy from four of its TAXUS...

(October, 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today presented data from its BEACH clinical trial, which was designed to evaluate the benefits of carotid artery stenting (CAS) in...

, and Washington, D.C. (October 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the combined results from the BLAZE and BLAZE II registries showing that its...

(October 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its third quarter ended September 30, 2005 and provided revised revenue and earnings-per-share...

(October 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today introduced a new program that will offer participating medical centers in the United States a TAXUS® Express2™ stent system...

(October 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a Dutch appeals court yesterday overturned a lower court ruling and reinstated an injunction against the...

(October 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company

(October 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30, 2005 on Friday, October 14,...

(October 4, 2005)

(October 3, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the grand opening of its new Maple Grove, Minnesota Research and Development facility, which includes several...

(September 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today the grand opening of its new Marlborough, Massachusetts office complex, which serves as the new headquarters for...

(September 16, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Flextome™ Cutting...

(September 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Wayne, New Jersey manufacturing facility has been named one of the 10 best plants in North America by...

(September 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received CE Mark for the Precision™ Spinal Cord Stimulation (SCS) system, Europe

(September 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an article in the Journal of the American Medical Association (JAMA) on the TAXUS V clinical trial that found the TAXUS

(September 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received CE Mark for its TAXUS® Liberté™ paclitaxel-eluting stent system, the world

(September 8, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that three of its drug-eluting stent clinical trials have been recognized as meeting the treatment guidelines of...

(September 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) today commented on its third quarter performance. Speaking at the 2005 Thomas Weisel Partners Healthcare Conference in Boston,...

(September 6, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bear Stearns 18th Annual Healthcare Conference, which is being held September 12 and 13 in New...

(September 1, 2005)

(September 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Thomas Weisel Partners Healthcare Conference, which is being held September 7 - 9 in...

(August 16, 2005)

(August 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has granted a Humanitarian Device Exemption (HDE) approval for the...

(August 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the initial activation of bilateral cochlear implants for 14-month-old identical-twin girls at the California Ear...

(July 28, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received the 2005 Best Practices in Logistics Management Gold Award from Logistics Management magazine, a...

(July 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its second quarter ended June 30, 2005. Highlights: Net sales of $1.6 billion, an increase of 11...

(July 11, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that physicians have implanted the 1,000th Precision™ Spinal Cord Stimulation System for the treatment of chronic...